Fresh Tracks Therapeutics (FRTX) Short Interest Ratio & Short Volume

Short interest is the volume of Fresh Tracks Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 28th, investors have sold 400 shares of FRTX short. Learn More on Fresh Tracks Therapeutics' current short interest.

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Fresh Tracks Therapeutics: BioAtla, Inc. (10.14%), Passage Bio, Inc. (3.31%), Relmada Therapeutics, Inc. (4.93%), MIRA Pharmaceuticals, Inc. (3.63%), Sol-Gel Technologies Ltd. (2.13%), NeuroSense Therapeutics Ltd. (1.67%), Q32 Bio Inc. (14.12%), Natural Alternatives International, Inc. (0.16%), Ovid Therapeutics Inc. (2.74%), Chemomab Therapeutics Ltd. (0.47%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), Strategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks.

Short selling FRTX is an investing strategy that aims to generate trading profit from Fresh Tracks Therapeutics as its price is falling. FRTX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Fresh Tracks Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of FRTX, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FRTX, twice per month. The most recent reporting period available is February, 28 2025.